Company Overview

Update
Founded:
2006
Headquarters:
Dublin
Funding:
$4.5M
Categories:
Biotechnology
Description:
Biosensia is a diagnostics company developing point-of-care platforms used for a variety of common biological sample types.

Detailed Description

Update

Biosensia is a Point-of-Care in-vitro diagnostics company that has a novel point-of-care platform, RapiPlex, available for licensing.

RapiPlex combines highly innovative technologies to produce a practical, rapid, multiplexing POC in-vitro diagnostics (IVD) platform, enabling access to a broad range of diagnostic applications.

Its component chip and cartridge system are compatible with a variety of common biological sample types, including whole blood, serum, saliva, urine and nasal/genital swabs.

Current Team (1)

Update

Past Team (1)

Update

Funding Rounds (2) - $4.5M

Update

Investors (5)

Update
  • 12dbd02be617c3d755ea5f62746af208

    Atlantic Bridge

    Atlantic Bridge is a private equity firm with offices in Dublin and London, focusing on Middle...
  • Ce4648794297748d49e46e1af45f661f

    ACT Venture Capital

    Venture Capital
  • 200323d551c50636d9df61f36d72cd5f

    Seroba Kernel

    Seroba Kernel Life Sciences Limited (Seroba Kernel) is a European life science venture capital...
  • 433f38846d632daf957e50005ce153cd

    Enterprise Ireland

    Agency Supporting Irish Companies
  • 3568c586d693a3ab56b14f466033007b

    Street Capital

    Street Capital Financial Corporation is a Canadian wholesale lending company. As a wholesale...

Offices/Locations (1)

Update
  • HQ

    Belfield Innovation Park

    Dublin,

    IRL

Images (1)

Update
  • F375b9050dcf389eb1eb76c5a1a8a143